Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | BLLN BillionToOne, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $105.92 -4.3% | $15.06 -2.0% |
| StockIQ Score | 57C Moderate Risk: Medium | 36F Weak Risk: Medium |
| Technical | 59C | 13F |
| Fundamental | 54C- | 35F |
| Growth | 82A- | 50C- |
| Fair Value | 33F | 38F |
| News | 50C- | 50C- |
| Quality | 63C+ | 50C- |
| Risk | 54C- | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
BillionToOne (BLLN) outperforms Ascentage Pharma (AAPG) in growth (82 vs. 50) and fundamental analysis (54 vs. 35), showing stronger potential for expansion and financial health. However, AAPG has a slightly better valuation score (38 vs. 33) and a higher investor score (37 vs. 50), though BLLN’s overall rating is moderate compared to AAPG’s weak rating. Technical strength favors BLLN significantly (33 vs. 18).